Financhill
Back

Apellis Pharmaceuticals Vs. Madrigal Pharmaceuticals Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
43.22
Seasonality Move:
9.35%
Buy
60

MDGL
Madrigal Pharmaceuticals

Last Price:
232.18
Seasonality Move:
-9.8%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $43.22. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $232.10. The Score for MDGL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $43.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $232.10
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.83 Sell
Relative Strength Index (14 RSI): 40.9 Sell
Chaikin Money Flow: 822657 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.64 - 48.9) Sell
Bollinger Bands (100): (49.68 - 66.88) Sell

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 57.64 Buy
Chaikin Money Flow: 300012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (203.14 - 225.6) Buy
Bollinger Bands (100): (211.08 - 251.3) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.15 Buy
20-day SMA: 45.09 Sell
50-day SMA: 51.11 Sell
200-day SMA: 51.84 Sell
8-day EMA: 42.69 Buy
20-day EMA: 45 Sell
50-day EMA: 50.12 Sell
200-day EMA: 55.46 Sell

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 214.47 Buy
20-day SMA: 212.48 Buy
50-day SMA: 233.74 Sell
200-day SMA: 201.95 Buy
8-day EMA: 218.46 Buy
20-day EMA: 218.03 Buy
50-day EMA: 224.68 Buy
200-day EMA: 216.07 Buy

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.34 per share, an increase this year of $3.60 per share, and an increase next year of $2.16 per share.

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):